Stock GLMD GALMED PHARMACEUTICALS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Galmed Pharmaceuticals Ltd.

Equities

GLMD

IL0011313900

Market Closed - Nasdaq
Other stock markets
 02:00:00 27/04/2024 am IST 		5-day change 1st Jan Change
0.3916 USD -0.23% Intraday chart for Galmed Pharmaceuticals Ltd. +5.04% -13.93%
04/04 Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
15/03 Galmed Pharmaceuticals Ltd. Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of Nash and Liver Fibrosis CI

Chart calendar Galmed Pharmaceuticals Ltd.

59f07ef370adc2ada012a5abdf9b0.HOYsXfTLu70LWKnxDXtOa81sGlpIPMFjnOLtGCSnLMU.b55oBLu52uRBDOTAYgslIb0BbxMwY6U704mhUUzjTqR1j1gQq6nZ71M2-A~bb925be91eae4380ae8f7230355eeb2c

Upcoming events on Galmed Pharmaceuticals Ltd.

08/05/2024 Q1 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Galmed Pharmaceuticals Ltd.

20/06/2023 06:30 pm Maxim Group Virtual Healthcare Conference
01/06/2023 05:30 pm Q1 2023 Earnings Release
04/05/2023 07:30 pm Annual General Meeting
04/08/2022 05:30 pm Interim 2022 Earnings Release
17/05/2022 05:30 pm Q1 2022 Earnings Release
02/05/2022 06:00 pm FY 2021 Earnings Call
02/05/2022 04:30 pm FY 2021 Earnings Release
12/11/2021 AASLD The Liver Meeting
08/11/2021 07:00 pm Q3 2021 Earnings Call - ARMOR Phase 3 Study Update
08/11/2021 06:00 pm Q3 2021 Earnings Release
05/08/2021 06:00 pm Interim 2021 Earnings Call
05/08/2021 04:30 pm Interim 2021 Earnings Release
13/05/2021 06:00 pm Q1 2021 Earnings Call
13/05/2021 05:20 pm Q1 2021 Earnings Release
18/03/2021 06:00 pm FY 2020 Earnings Call
18/03/2021 04:30 pm FY 2020 Earnings Release
18/11/2020 06:30 pm Stifel Healthcare Conference
12/11/2020 07:00 pm Q3 2020 Earnings Call
12/11/2020 05:30 pm Q3 2020 Earnings Release
06/08/2020 06:00 pm Interim 2020 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		-20,1
-20,0
-0.55%		-28,1
-23,3
-20.62%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-22,4
-21,6
-3.78%		-30,2
-27,7
-9.15%		-32,9
-34,2
3.75%		-17,7
-18,9
6.43%		-7,49
-8,20
8.6%
-10,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-20,5
-19,8
-3.27%		-28,8
-26,2
-9.61%		-32,5
-33,6
3.28%		-17,9
-18,9
5.32%		-6,91
-7,75
10.78%
-10,6

Net income
Million USD		Released
Forecast
Spread 		-20,5
-19,8
-3.27%		-28,8
-26,2
-9.61%		-32,5
-33,5
3.11%		-17,9
-18,9
5.32%		-6,91
-7,75
10.78%
-10,6

EPS
USD		Released
Forecast
Spread 		-14,5
-14,1
-3.47%		-20,2
-18,6
-9.05%		-19,8
-19,8
0.15%		-10,6
-11,2
5.33%		-2,50
-2,63
4.94%
-1,29

Announcement Date12/03/2018/03/2102/05/2229/03/2304/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		-7,49
-8,95
16.3%		-6,09
-8,27
26.36%		-3,73
-6,56
43.11%		-5,38
-4,19
-28.32%		-2,45
-3,66
33.11%		-2,00
-2,50
19.86%		-1,87
-2,04
8.37%		-1,47
-1,97
25.6%		-2,15
-2,35
8.51%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-7,45
-8,55
12.83%		-6,14
-8,25
25.56%		-3,37
-6,54
48.39%		-5,35
-4,16
-28.54%		-2,64
-3,64
27.54%		-1,83
-2,50
26.74%		-1,59
-2,04
21.99%		-1,47
-1,97
25.34%		-2,02
-2,35
14.25%
Net income
Million USD		Released
Forecast
Spread 		-7,45
-8,55
12.83%		-6,14
-8,25
25.56%		-3,37
-6,54
48.39%		-5,35
-4,16
-28.54%		-2,64
-3,64
27.54%		-1,83
-2,50
26.74%		-1,59
-2,04
21.99%		-1,47
-1,97
25.34%		-2,02
-2,35
14.25%
EPS
USD		Released
Forecast
Spread 		-4,50
-4,54
0.83%		-3,60
-4,80
25%		-2,25
-3,54
36.44%		-3,15
-2,48
-27.27%		-1,50
-2,10
28.57%		-1,09
-1,50
27.33%		-0,95
-0,34
-179.41%		-0,24
-0,27
11.11%		-0,22
-0,32
31.25%
Announcement Date02/05/2217/05/2204/08/2216/11/2229/03/2301/06/2309/08/2322/11/2304/04/24

Upcoming sector events for Galmed Pharmaceuticals Ltd.

29/04/2024 HITGEN INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
30/04/2024 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
30/04/2024 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
01/05/2024 01:35 am EXELIXIS, INC.: Q1 2024 Earnings Release
01/05/2024 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
01/05/2024 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Galmed Pharmaceuticals Ltd.

26/04/2024 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
26/04/2024 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
26/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
26/04/2024 REMEGEN CO., LTD.: Q1 2024 Earnings Release
26/04/2024 01:35 am PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 04:00 pm SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GLMD Stock
  4. Calendar Galmed Pharmaceuticals Ltd.